期刊
SCIENCE ADVANCES
卷 9, 期 27, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.ade6958
关键词
-
Cancer cell-derived extracellular vesicles (EVs) could be potential targets for disease biomarkers due to their unique protein profiles. Analysis of small EVs (sEVs) and medium/large EVs (m/lEVs) revealed that both subtypes had distinct proteomic characteristics. Specific sEV proteins (FRa, Claudin-3, and TACSTD2) for high-grade serous ovarian carcinoma (HGSOC) were identified, while no candidates were found for m/lEVs. Additionally, a microfluidic device using polyketone-coated nanowires (pNWs) was developed for efficient sEV isolation and showed specific detectability in cancer patients and predicted clinical status.
Cancer cell-derived extracellular vesicles (EVs) have unique protein profiles, making them promising targets as disease biomarkers. High-grade serous ovarian carcinoma (HGSOC) is the deadly subtype of epithelial ovarian cancer, and we aimed to identify HGSOC-specific membrane proteins. Small EVs (sEVs) and medium/large EVs (m/lEVs) from cell lines or patient serum and ascites were analyzed by LC-MS/MS, revealing that both EV subtypes had unique proteomic characteristics. Multivalidation steps identified FRa, Claudin-3, and TACSTD2 as HGSOC-specific sEV proteins, but m/lEV-associated candidates were not identified. In addition, for using a simple-to-use microfluidic device for EV isolation, polyketone-coated nanowires (pNWs) were developed, which efficiently purify sEVs from biofluids. Multiplexed array assays of sEVs isolated by pNW showed specific detectability in cancer patients and predicted clinical status. In summary, the HGSOC-specific marker detection by pNW are a promising platform as clinical biomarkers, and these insights provide detailed proteomic aspects of diverse EVs in HGSOC patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据